Published in Proc Natl Acad Sci U S A on August 18, 2003
Progesterone receptors: form and function in brain. Front Neuroendocrinol (2008) 2.15
Protective actions of sex steroid hormones in Alzheimer's disease. Front Neuroendocrinol (2009) 1.71
Estradiol-induced enhancement of object memory consolidation involves hippocampal extracellular signal-regulated kinase activation and membrane-bound estrogen receptors. J Neurosci (2008) 1.56
Progesterone exerts neuroprotective effects after brain injury. Brain Res Rev (2007) 1.54
Estrogens and age-related memory decline in rodents: what have we learned and where do we go from here? Horm Behav (2008) 1.39
Role of progesterone in nicotine addiction: evidence from initiation to relapse. Exp Clin Psychopharmacol (2010) 1.38
Sex, sex steroids, and brain injury. Semin Reprod Med (2009) 1.35
Estrogens and progesterone as neuroprotectants: what animal models teach us. Front Biosci (2008) 1.25
Hormone therapy and cognitive function. Hum Reprod Update (2009) 1.22
Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects. Endocr Rev (2012) 1.20
Progesterone increases rat neural progenitor cell cycle gene expression and proliferation via extracellularly regulated kinase and progesterone receptor membrane components 1 and 2. Endocrinology (2009) 1.15
Estradiol-induced object memory consolidation in middle-aged female mice requires dorsal hippocampal extracellular signal-regulated kinase and phosphatidylinositol 3-kinase activation. J Neurosci (2010) 1.13
Progesterone with vitamin D affords better neuroprotection against excitotoxicity in cultured cortical neurons than progesterone alone. Mol Med (2009) 1.08
Sex differences in cognitive impairment and Alzheimer's disease. Front Neuroendocrinol (2014) 1.08
Progesterone action in human tissues: regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expression. Nucl Recept Signal (2009) 1.08
Progesterone-estrogen interactions in synaptic plasticity and neuroprotection. Neuroscience (2012) 1.07
Progesterone improves cognitive performance and attenuates smoking urges in abstinent smokers. Psychoneuroendocrinology (2010) 1.03
Estrogen receptor beta as a mitochondrial vulnerability factor. J Biol Chem (2009) 1.02
Progesterone reverses 17beta-estradiol-mediated neuroprotection and BDNF induction in cultured hippocampal slices. Eur J Neurosci (2009) 1.01
Differential effects on visual and spatial recognition memory of a novel hormone therapy regimen of estrogen alone or combined with progesterone in older surgically menopausal monkeys. Neuroscience (2008) 0.97
The differences in neuroprotective efficacy of progesterone and medroxyprogesterone acetate correlate with their effects on brain-derived neurotrophic factor expression. Endocrinology (2009) 0.96
Clinically relevant progestins regulate neurogenic and neuroprotective responses in vitro and in vivo. Endocrinology (2010) 0.95
Gender and sex hormones in multiple sclerosis pathology and therapy. Front Biosci (Landmark Ed) (2009) 0.95
Estrogen Effects on Cognitive and Synaptic Health Over the Lifecourse. Physiol Rev (2015) 0.95
The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells. Breast Cancer Res (2005) 0.94
Post-training progesterone dose-dependently enhances object, but not spatial, memory consolidation. Behav Brain Res (2008) 0.94
Hormonal influences on cognition and risk for Alzheimer's disease. Curr Neurol Neurosci Rep (2010) 0.94
Estradiol-17beta-induced human neural progenitor cell proliferation is mediated by an estrogen receptor beta-phosphorylated extracellularly regulated kinase pathway. Endocrinology (2007) 0.94
Progesterone increases the release of brain-derived neurotrophic factor from glia via progesterone receptor membrane component 1 (Pgrmc1)-dependent ERK5 signaling. Endocrinology (2012) 0.94
Neurosteroids' effects and mechanisms for social, cognitive, emotional, and physical functions. Psychoneuroendocrinology (2009) 0.94
A second chance for hormone replacement therapy? EMBO Rep (2003) 0.93
Progesterone-induced neuroprotection: factors that may predict therapeutic efficacy. Brain Res (2013) 0.93
Differential effects of acute progesterone administration on spatial and object memory in middle-aged and aged female C57BL/6 mice. Horm Behav (2008) 0.93
Dorsal hippocampal progesterone infusions enhance object recognition in young female mice. Pharmacol Biochem Behav (2009) 0.93
Combination treatment with progesterone and vitamin D hormone is more effective than monotherapy in ischemic stroke: the role of BDNF/TrkB/Erk1/2 signaling in neuroprotection. Neuropharmacology (2012) 0.92
Building a better hormone therapy? How understanding the rapid effects of sex steroid hormones could lead to new therapeutics for age-related memory decline. Behav Neurosci (2012) 0.92
Cognitive changes after menopause: influence of estrogen. Clin Obstet Gynecol (2008) 0.91
Spinal estrogen receptor alpha mediates estradiol-induced pronociception in a visceral pain model in the rat. Pain (2011) 0.91
Progesterone and neuroprotection. Horm Behav (2012) 0.91
Dose-dependent effects of post-training estradiol plus progesterone treatment on object memory consolidation and hippocampal extracellular signal-regulated kinase activation in young ovariectomized mice. Neuroscience (2009) 0.90
Novel progesterone receptors: neural localization and possible functions. Front Neurosci (2013) 0.89
A new approach to understanding the molecular mechanisms through which estrogens affect cognition. Biochim Biophys Acta (2009) 0.89
Progesterone, brain-derived neurotrophic factor and neuroprotection. Neuroscience (2012) 0.89
Alzheimer's disease: review of hormone therapy trials and implications for treatment and prevention after menopause. J Steroid Biochem Mol Biol (2013) 0.89
Progesterone potentiates calcium release through IP3 receptors by an Akt-mediated mechanism in hippocampal neurons. Cell Calcium (2008) 0.89
Post-translational modifications of the progesterone receptors. J Steroid Biochem Mol Biol (2013) 0.88
Progesterone and medroxyprogesterone acetate differentially regulate alpha4 subunit expression of GABA(A) receptors in the CA1 hippocampus of female rats. Physiol Behav (2009) 0.88
Estrogen and hippocampal plasticity in rodent models. J Alzheimers Dis (2008) 0.88
Medroxyprogesterone acetate antagonizes estrogen up-regulation of brain mitochondrial function. Endocrinology (2010) 0.87
Molecular mechanisms underlying the memory-enhancing effects of estradiol. Horm Behav (2015) 0.87
Non-genomic mechanisms of progesterone action in the brain. Front Neurosci (2013) 0.86
Frontiers proposal. National Institute on Aging "bench to bedside: estrogen as a case study". Age (Dordr) (2009) 0.86
The effects of long-term treatment with estradiol and medroxyprogesterone acetate on tyrosine hydroxylase fibers and neuron number in the medial prefrontal cortex of aged female rats. Endocrinology (2012) 0.86
Continuous versus cyclic progesterone exposure differentially regulates hippocampal gene expression and functional profiles. PLoS One (2012) 0.85
Aging, estrogens, and episodic memory in women. Cogn Behav Neurol (2009) 0.83
Glucocorticoid and polyamine interactions in the plasticity of glutamatergic synapses that contribute to ethanol-associated dependence and neuronal injury. Addict Biol (2011) 0.83
Epigenetic regulation of estrogen-dependent memory. Front Neuroendocrinol (2014) 0.83
Progesterone inhibition of neuronal calcium signaling underlies aspects of progesterone-mediated neuroprotection. J Steroid Biochem Mol Biol (2011) 0.82
Postmenopausal hormone therapy is not associated with risk of all-cause dementia and Alzheimer's disease. Epidemiol Rev (2013) 0.81
Effects of long-term treatment with estrogen and medroxyprogesterone acetate on synapse number in the medial prefrontal cortex of aged female rats. Menopause (2012) 0.80
Factors influencing the cognitive and neural effects of hormone treatment during aging in a rodent model. Brain Res (2013) 0.80
Progesterone facilitates exploration, affective and social behaviors among wildtype, but not 5α-reductase Type 1 mutant, mice. Behav Brain Res (2013) 0.80
Prevention of coronary hyperreactivity in preatherogenic menopausal rhesus monkeys by transdermal progesterone. Arterioscler Thromb Vasc Biol (2004) 0.78
Use of estetrol with other steroids for attenuation of neonatal hypoxic-ischemic brain injury: to combine or not to combine? Oncotarget (2016) 0.78
A preliminary study on progesterone antioxidation in promoting learning and memory of young ovariectomized mice. Arch Med Sci (2011) 0.78
Identification of a regulatory loop for the synthesis of neurosteroids: a steroidogenic acute regulatory protein-dependent mechanism involving hypothalamic-pituitary-gonadal axis receptors. J Neurochem (2009) 0.78
Hormonal modulators of glial ABCA1 and apoE levels. J Lipid Res (2013) 0.77
MPA: medroxy-progesterone acetate contributes to much poor advice for women. Endocrinology (2011) 0.76
Why estrogens matter for behavior and brain health. Neurosci Biobehav Rev (2016) 0.75
A comparison of progestins within three classes: Differential effects on learning and memory in the aging surgically menopausal rat. Behav Brain Res (2016) 0.75
Challenges facing age-management/longevity medicine. Clin Interv Aging (2007) 0.75
Modulatory Effects of Sex Steroids Progesterone and Estradiol on Odorant Evoked Responses in Olfactory Receptor Neurons. PLoS One (2016) 0.75
Effects of progesterone and vitamin D on outcome of patients with acute traumatic spinal cord injury; a randomized, double-blind, placebo controlled study. J Spinal Cord Med (2015) 0.75
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37
Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell (1994) 9.73
Nuclear localization and regulation of erk- and rsk-encoded protein kinases. Mol Cell Biol (1992) 7.72
Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA (2002) 6.72
Oral contraceptives and the risk of breast cancer. N Engl J Med (2002) 4.85
Regulation and properties of extracellular signal-regulated protein kinases 1 and 2 in vitro. J Biol Chem (1993) 3.57
Ionic dependence of glutamate neurotoxicity. J Neurosci (1987) 3.01
Interaction of MAP kinase with MAP kinase kinase: its possible role in the control of nucleocytoplasmic transport of MAP kinase. EMBO J (1997) 2.99
Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate. Endocrinology (2002) 2.01
Two co-existing mechanisms for nuclear import of MAP kinase: passive diffusion of a monomer and active transport of a dimer. EMBO J (1999) 1.90
Cholesterol depletion of caveolae causes hyperactivation of extracellular signal-related kinase (ERK). J Biol Chem (1998) 1.82
Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: convergence of estrogen and neurotrophin signaling pathways. J Neurosci (1999) 1.78
The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J Neurosci (1999) 1.76
Neuroprotective effects of estrogens: potential mechanisms of action. Int J Dev Neurosci (2000) 1.75
Nuclear translocation of mitogen-activated protein kinase kinase (MEK1) in response to mitogenic stimulation. Proc Natl Acad Sci U S A (1997) 1.72
Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm. Nat Med (1997) 1.70
Growth factor-induced p42/p44 MAPK nuclear translocation and retention requires both MAPK activation and neosynthesis of nuclear anchoring proteins. J Cell Biol (1998) 1.69
Mechanism of estrogen-mediated neuroprotection: regulation of mitochondrial calcium and Bcl-2 expression. Proc Natl Acad Sci U S A (2003) 1.51
Estrogen activation of cyclic adenosine 5'-monophosphate response element-mediated transcription requires the extracellularly regulated kinase/mitogen-activated protein kinase pathway. Endocrinology (2003) 1.36
The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement. Br J Obstet Gynaecol (1992) 1.32
Estradiol is a protective factor in the adult and aging brain: understanding of mechanisms derived from in vivo and in vitro studies. Brain Res Brain Res Rev (2001) 1.24
Impact of progestins on estradiol potentiation of the glutamate calcium response. Neuroreport (2002) 1.22
Dual action of estrogen on glutamate-induced calcium signaling: mechanisms requiring interaction between estrogen receptors and src/mitogen activated protein kinase pathway. Brain Res (2002) 1.18
Estrogen and stroke: a balanced analysis. Stroke (2003) 1.14
Clinical review 108: The molecular and neuroanatomical basis for estrogen effects in the central nervous system. J Clin Endocrinol Metab (1999) 1.11
Cellular and molecular mechanisms of estrogen regulation of memory function and neuroprotection against Alzheimer's disease: recent insights and remaining challenges. Learn Mem (2001) 1.06
Prevention of endometrial cancer with progestogens. Maturitas (1986) 1.00
Mitogen-activated protein kinase/extracellular signal-regulated kinase 2 regulates cytoskeletal organization and chemotaxis via catalytic and microtubule-specific interactions. Mol Biol Cell (1997) 0.99
Cellular components of nerve growth factor signaling. Biochim Biophys Acta (1994) 0.90
Progestins. Maturitas (1996) 0.87
Estradiol-induced phosphorylation of ERK1/2 in explants of the mouse cerebral cortex: the roles of heat shock protein 90 (Hsp90) and MEK2. J Neurobiol (2002) 0.86
Gene activation pathways of nerve growth factor signaling: a minireview. Neurobiology (Bp) (1996) 0.84
Oestrogens and dementia. Novartis Found Symp (2000) 0.84
Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A (2009) 3.31
Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate. Endocrinology (2002) 2.01
Estrogen receptor alpha and beta differentially regulate intracellular Ca(2+) dynamics leading to ERK phosphorylation and estrogen neuroprotection in hippocampal neurons. Brain Res (2007) 1.53
Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons. Brain Res (2004) 1.47
The neurosteroid allopregnanolone promotes proliferation of rodent and human neural progenitor cells and regulates cell-cycle gene and protein expression. J Neurosci (2005) 1.46
Progesterone and estrogen regulate oxidative metabolism in brain mitochondria. Endocrinology (2008) 1.46
Mitochondria as therapeutic targets of estrogen action in the central nervous system. Curr Drug Targets CNS Neurol Disord (2004) 1.38
Estradiol in vivo regulation of brain mitochondrial proteome. J Neurosci (2007) 1.36
Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A (2010) 1.27
Impact of progestins on estradiol potentiation of the glutamate calcium response. Neuroreport (2002) 1.22
Dose and temporal pattern of estrogen exposure determines neuroprotective outcome in hippocampal neurons: therapeutic implications. Endocrinology (2006) 1.21
Estrogen protects neuronal cells from amyloid beta-induced apoptosis via regulation of mitochondrial proteins and function. BMC Neurosci (2006) 1.19
Dual action of estrogen on glutamate-induced calcium signaling: mechanisms requiring interaction between estrogen receptors and src/mitogen activated protein kinase pathway. Brain Res (2002) 1.18
Menopause and mitochondria: windows into estrogen effects on Alzheimer's disease risk and therapy. Prog Brain Res (2010) 1.16
Progesterone increases rat neural progenitor cell cycle gene expression and proliferation via extracellularly regulated kinase and progesterone receptor membrane components 1 and 2. Endocrinology (2009) 1.15
2-Deoxy-D-glucose treatment induces ketogenesis, sustains mitochondrial function, and reduces pathology in female mouse model of Alzheimer's disease. PLoS One (2011) 1.14
Decline in mitochondrial bioenergetics and shift to ketogenic profile in brain during reproductive senescence. Biochim Biophys Acta (2010) 1.06
Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions. Mol Aspects Med (2011) 1.05
17β-Estradiol regulates insulin-degrading enzyme expression via an ERβ/PI3-K pathway in hippocampus: relevance to Alzheimer's prevention. Neurobiol Aging (2010) 1.04
Activation of estrogen receptor alpha increases and estrogen receptor beta decreases apolipoprotein E expression in hippocampus in vitro and in vivo. Proc Natl Acad Sci U S A (2006) 1.03
Regenerative potential of allopregnanolone. Brain Res Rev (2007) 1.02
Estrogenic agonist activity of ICI 182,780 (Faslodex) in hippocampal neurons: implications for basic science understanding of estrogen signaling and development of estrogen modulators with a dual therapeutic profile. J Pharmacol Exp Ther (2006) 1.02
A select combination of clinically relevant phytoestrogens enhances estrogen receptor beta-binding selectivity and neuroprotective activities in vitro and in vivo. Endocrinology (2008) 1.00
Ovarian hormone loss induces bioenergetic deficits and mitochondrial β-amyloid. Neurobiol Aging (2011) 0.97
WHI and WHIMS follow-up and human studies of soy isoflavones on cognition. Expert Rev Neurother (2007) 0.96
Allopregnanolone restores hippocampal-dependent learning and memory and neural progenitor survival in aging 3xTgAD and nonTg mice. Neurobiol Aging (2011) 0.96
Clinically relevant progestins regulate neurogenic and neuroprotective responses in vitro and in vivo. Endocrinology (2010) 0.95
Allopregnanolone promotes regeneration and reduces β-amyloid burden in a preclinical model of Alzheimer's disease. PLoS One (2011) 0.95
Estradiol-17beta-induced human neural progenitor cell proliferation is mediated by an estrogen receptor beta-phosphorylated extracellularly regulated kinase pathway. Endocrinology (2007) 0.94
Estrogen regulation of mitochondrial bioenergetics: implications for prevention of Alzheimer's disease. Adv Pharmacol (2012) 0.93
Impact of the selective estrogen receptor modulator, raloxifene, on neuronal survival and outgrowth following toxic insults associated with aging and Alzheimer's disease. Exp Neurol (2004) 0.90
Regeneration in a degenerating brain: potential of allopregnanolone as a neuroregenerative agent. Curr Alzheimer Res (2007) 0.89
Allopregnanolone-induced rise in intracellular calcium in embryonic hippocampal neurons parallels their proliferative potential. BMC Neurosci (2008) 0.88
Early decline in glucose transport and metabolism precedes shift to ketogenic system in female aging and Alzheimer's mouse brain: implication for bioenergetic intervention. PLoS One (2013) 0.88
A dominant negative ERβ splice variant determines the effectiveness of early or late estrogen therapy after ovariectomy in rats. PLoS One (2012) 0.88
Neuronal network morphology and electrophysiologyof hippocampal neurons cultured on surface-treated multielectrode arrays. IEEE Trans Biomed Eng (2007) 0.88
Medroxyprogesterone acetate exacerbates glutamate excitotoxicity. Gynecol Endocrinol (2006) 0.87
Medroxyprogesterone acetate antagonizes estrogen up-regulation of brain mitochondrial function. Endocrinology (2010) 0.87
Ovariectomy induces a shift in fuel availability and metabolism in the hippocampus of the female transgenic model of familial Alzheimer's. PLoS One (2013) 0.86
Frontiers proposal. National Institute on Aging "bench to bedside: estrogen as a case study". Age (Dordr) (2009) 0.86
17β-estradiol and progesterone regulate expression of β-amyloid clearance factors in primary neuron cultures and female rat brain. Endocrinology (2012) 0.85
Considerations in the design of clinical trials for cognitive aging. J Gerontol A Biol Sci Med Sci (2012) 0.85
Vasopressin-induced cytoplasmic and nuclear calcium signaling in embryonic cortical astrocytes: dynamics of calcium and calcium-dependent kinase translocation. J Neurosci (2003) 0.85
Neuroregenerative mechanisms of allopregnanolone in Alzheimer's disease. Front Endocrinol (Lausanne) (2012) 0.84
Estrogen protection against mitochondrial toxin-induced cell death in hippocampal neurons: antagonism by progesterone. Brain Res (2010) 0.83
Allopregnanolone increases the number of dopaminergic neurons in substantia nigra of a triple transgenic mouse model of Alzheimer's disease. Curr Alzheimer Res (2012) 0.82
Effects of estrogen plus progestin on risk of dementia. JAMA (2003) 0.82
Potentiation of brain mitochondrial function by S-equol and R/S-equol estrogen receptor β-selective phytoSERM treatments. Brain Res (2013) 0.81
Hippocampal responsiveness to 17β-estradiol and equol after long-term ovariectomy: implication for a therapeutic window of opportunity. Brain Res (2011) 0.81
Targeting mitochondrial bioenergetics for Alzheimer's prevention and treatment. Curr Pharm Des (2011) 0.80
Allopregnanolone reinstates tyrosine hydroxylase immunoreactive neurons and motor performance in an MPTP-lesioned mouse model of Parkinson's disease. PLoS One (2012) 0.80
Impact of clinically relevant progestins on the neural effects of estradiol and the signaling pathways involved. Drug News Perspect (2005) 0.79
Window of opportunity for estrogen and progestin intervention in brain aging and Alzheimer's disease. Brain Res (2013) 0.78
Vasopressin-induced cytoplasmic and nuclear calcium signaling in cultured cortical astrocytes. Brain Res (2002) 0.77
The effect of dietary soy isoflavones before and after ovariectomy on hippocampal protein markers of mitochondrial bioenergetics and antioxidant activity in female monkeys. Brain Res (2011) 0.77
Targeting the prodromal stage of Alzheimer's disease: bioenergetic and mitochondrial opportunities. Neurotherapeutics (2015) 0.75
Turning students into science stars. IEEE Eng Med Biol Mag (2005) 0.75